艰难梭菌感染治疗的最新进展
摘要
艰难梭菌是引发传染性结肠炎的主要原因，在住院病人和长期居住在护理机构的病人中尤为普遍。过去十年里，艰难梭菌已越来越成为一个有问题的病原体。增强的毒性、传染性和无效的控制措施使艰难梭菌成为感染的主要原因。艰难梭菌感染（CDI）的历史疗法有着不可接受的高失败率和高复发率。
出处
《医学检验与临床》
2014年第3期46-48,76,共4页
Medical Laboratory Science and Clinics
参考文献20
-
1McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium diflficile. N. Engl. J. Med. 353(23),2433-2441(2005).
-
2Loo VG, Poirier L, Miller MA et al. A predominantly donal multi-institutional outbreak of Clostridium difficile- associated diarrhea with high morbidity and m0rtality.N,EngL J.Med.353(23),2442-2449(2005).
-
3Centers for Disease Control and Prevention(CDC), Severe Clostridiumdiffici-leassociated disease in populations previously at low risk-four states, 2005. MMWR Morb. Mortal. Wkly Rep. 54(47),1201-1205(2005).
-
4Warny M, Pepin J, Fang A et al: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491), 1079 - 1084(2005).
-
5Merrigan M, Venugopal A, Mallozzi Met al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J. Bacteri ol. 192 (19),4904-4911 (2010).
-
6Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31(5),431-455(2010).
-
7Cottreau J, Baker SF, Dupont HL, Garey KW. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Rev. Anti Infect.Ther 8(7),747- 760(2010).
-
8Garey KW, Ghantoji SS, Shah DN et al. A randomized, double-blind,placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J. Antimicrob. Chemother. 66(12),2850-2855(2011).
-
9Musher DM, Logan N, Bressler AM, Johnson DP, Rossignol JF. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized,double-blind study. Clin.Infect. Dis. 48(4),e41-e46(2009).
-
10Babakhani F, Bouillaut L, Gomez A, Sears P, Nguyen L, Sonenshein AL. Fidaxomicin inhibits spore production in Clostridium difficile. Clin. Infect. Dis. 55(Suppl. 2),S162-S169(2012).
-
1Lowy I,Molrine DC,Leav BA.单克隆抗体:治疗艰难梭菌感染有效[J].中国处方药,2010,9(2):67-67.
-
2林敏怡,陈烨.粪菌移植治疗复发性艰难梭菌感染[J].现代消化及介入诊疗,2014,19(6):411-414. 被引量：7
-
3强力霉素可预防头孢曲松相关艰难梭菌感染[J].中国社区医师,2012,28(23):17-17.
-
4陈亮恭,谢海雁.亚洲肌少症研究进展[J].中华老年多器官疾病杂志,2014,13(4):318-320. 被引量：4
-
5姬艳波(摘),王凤华(摘),苗松(校),刘晶瑶(校).肾性贫血病人的处置指南[J].国际护理学杂志,2008,27(9):1005-1006.
-
6吴晓尉,杨妙芳,陆恒,李楠,汪芳裕.炎症性肠病合并艰难梭菌感染1例报道[J].胃肠病学和肝病学杂志,2016,25(2):183-183.
-
7莫凌.艰难梭菌感染与外周血白细胞增多的关系[J].国外医学（微生物学分册）,2003,26(3):47-48.
-
8游洁玉,张文婷.粪菌移植治疗儿童艰难梭菌感染[J].中华实用儿科临床杂志,2017,32(7):494-496. 被引量：1
-
9熊号峰,刘景院,李兴旺.重症艰难梭菌感染者诊治研究进展[J].中华实验和临床感染病杂志（电子版）,2015,9(5):37-40. 被引量：2
-
10荀津,夏冰,彭谋,陈立平,王伟,易烽明.炎症性肠病与艰难梭菌感染的相关性[J].武汉大学学报（医学版）,2012,33(5):680-683. 被引量：9
